New vaccine for Omicron: Pfizer and Biontech have begun production
The German pharmaceutical company BioNTech and its American partner Pfizer have begun developing a COVID-19 vaccine customized to the omicron coronavirus strain, for subsequent commercial usage. According to BioNTech CEO Ugura Sahina, the manufacture of a COVID-19 vaccine customized to the omicron version has begun. Clinical studies on the vaccine will begin in late January. After…